Kyiv, Ukraine — May 26, 2025 — Enamine, the leading provider of chemical compounds and drug discovery services, today announced certain reference compounds from Pfizer are now available through Enamine`s marketplace and Enamine`s integration capabilities (i.e. punchout site, hosted catalogs, and API solutions). This allows researchers to explore and purchase from the catalog of selected Pfizer-provided drugs, chemical dormants, investigational compounds, and isotope-labelled molecules with appropriate quality control.
Iryna Yavnyuk, CEO of Enamine US, Inc. comments: For over 30 years, Enamine has remained the world’s leading provider of small molecules, having the largest in-stock catalog of screening compounds and building blocks. Our goal has remained the same over the years: support research programs around the world to contribute to global science. Having added selected Pfizer-provided compounds to our offerings, we will make sure our customers will have access to a broader diversity of chemicals in one place.